FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616439347> ?p ?o ?g. }

• W2616439347 endingPage "S36" @default.
• W2616439347 startingPage "S36" @default.
• W2616439347 abstract "Introduction: Immune graft rejection is the main obstacle to successful transplants. Immunosuppressive drugs fail to prevent chronic rejection and also impair the immune system, resulting in reduced lifetime survival rates. Transfer of regulatory T cells (Treg) has acquired growing interest in attempts to achieve indefinite graft survival [1]. The limited Treg numbers that can be purified from peripheral blood, along with low survival and limited suppressive capacity of expanded Treg obtained from adults, constitute important drawbacks for the effectiveness of this strategy. Methods: We established a collaboration amongst several teams working in the field to overcome current barriers and make Treg therapy a reality equipped to achieve indefinite graft survival. The major innovation is the employment of thymus, the site of Treg generation, as a new source of Treg [2]. Our goal is to perform a first-in-human trial treating heart-transplanted children with autologous thymus-derived Treg (thy-Treg) to prevent graft rejection. Results: We purified Treg from thymuses discarded routinely during cardiac surgeries in children with congenital diseases, obtaining massive quantities of thy-Treg with >98% purity. The final thy-Treg product shows high suppressive capacity, decreasing the proliferation of CD4+ and CD8+ T cells in co-cultures by more than 70%. Next, we propose to conduct a clinical trial transferring thy-Treg to heart-transplanted children. In the first instance, thymuses removed during transplant surgery will be processed in GMP-conditions, and autologous thy-Treg will be infused back to the patient at day +10, when immunosuppressant doses are routinely reduced. Due to the high quality and quantity of these thy-Treg and the favorable features of the pediatric immune system, we are confident that this strategy will boost Treg-mediated tolerance and reduce the incidence of graft rejection. Conclusion: Thymic tissue constitutes an alternative source of Treg that could be employed as cellular immunotherapy to prevent rejection. The massive quantity of Treg obtained from thymus, their high suppressive capacity, stability and survival, could overcome the drawbacks of employing Treg from peripheral blood. We propose that thy-Treg will constitute a therapeutic arsenal with infinite possibilities for the treatment of immune-related diseases, including graft rejection or autoimmune disorders.FIGURE 1: Purification and enrichment of thymus-derived Treg. Thymus tissue from one 5-months old chridren. Left: frequency of Treg cells in the total of thymocytes before pirification. Right: Highty Treg obtained after purification. Right: pure thynus-derived Treg obtained after pirification and 10-day culture.This work was supported by grants from Instituto de Salud Carlos III (ISCIII) co-financed by FEDER funds (PI15/00011; ICI14/00282).FIGURE 2: Suppressive capacity of thymus-derived Treg. Allogenic PBMCs were stained with CFSE and then co-cultured alone or with thymus derived Treg. (ratioPBMC:Treg 21). Proliferation ofCD4+ and CD8 T cells was analysed after 3 bays culture.References: 1. Safinia N, Scotta C, Vaikunthanathan T, Lechler RI, Lombardi G. Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation. Front Immunol. 2015 Aug 31;6:438. 2. Dijke IE, Hoeppli RE, Ellis T, Pearcey J, Huang Q, McMurchy AN, Boer K, Peeters AM, Aubert G, Larsen I, Ross DB, Rebeyka I, Campbell A, Baan CC, Levings MK, West LJ. Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells. Am J Transplant. 2016 Jan;16(1):58-71." @default.
• W2616439347 created "2017-05-26" @default.
• W2616439347 creator A5004888467 @default.
• W2616439347 creator A5010690912 @default.
• W2616439347 creator A5014181113 @default.
• W2616439347 creator A5037160225 @default.
• W2616439347 creator A5038480610 @default.
• W2616439347 creator A5043391533 @default.
• W2616439347 creator A5054910534 @default.
• W2616439347 creator A5068872849 @default.
• W2616439347 creator A5082278336 @default.
• W2616439347 creator A5086136249 @default.
• W2616439347 date "2017-05-01" @default.
• W2616439347 modified "2023-09-26" @default.
• W2616439347 title "Thymus-Derived Treg Infusion to Prevent Graft Rejection in Heart-Transplanted Children" @default.
• W2616439347 doi "https://doi.org/10.1097/01.tp.0000520350.40197.6b" @default.
• W2616439347 hasPublicationYear "2017" @default.
• W2616439347 type Work @default.
• W2616439347 sameAs 2616439347 @default.
• W2616439347 citedByCount "1" @default.
• W2616439347 countsByYear W26164393472018 @default.
• W2616439347 crossrefType "journal-article" @default.
• W2616439347 hasAuthorship W2616439347A5004888467 @default.
• W2616439347 hasAuthorship W2616439347A5010690912 @default.
• W2616439347 hasAuthorship W2616439347A5014181113 @default.
• W2616439347 hasAuthorship W2616439347A5037160225 @default.
• W2616439347 hasAuthorship W2616439347A5038480610 @default.
• W2616439347 hasAuthorship W2616439347A5043391533 @default.
• W2616439347 hasAuthorship W2616439347A5054910534 @default.
• W2616439347 hasAuthorship W2616439347A5068872849 @default.
• W2616439347 hasAuthorship W2616439347A5082278336 @default.
• W2616439347 hasAuthorship W2616439347A5086136249 @default.
• W2616439347 hasConcept C126322002 @default.
• W2616439347 hasConcept C167672396 @default.
• W2616439347 hasConcept C203014093 @default.
• W2616439347 hasConcept C2911091166 @default.
• W2616439347 hasConcept C3019230761 @default.
• W2616439347 hasConcept C71924100 @default.
• W2616439347 hasConcept C8891405 @default.
• W2616439347 hasConceptScore W2616439347C126322002 @default.
• W2616439347 hasConceptScore W2616439347C167672396 @default.
• W2616439347 hasConceptScore W2616439347C203014093 @default.
• W2616439347 hasConceptScore W2616439347C2911091166 @default.
• W2616439347 hasConceptScore W2616439347C3019230761 @default.
• W2616439347 hasConceptScore W2616439347C71924100 @default.
• W2616439347 hasConceptScore W2616439347C8891405 @default.
• W2616439347 hasIssue "5S-3" @default.
• W2616439347 hasLocation W26164393471 @default.
• W2616439347 hasOpenAccess W2616439347 @default.
• W2616439347 hasPrimaryLocation W26164393471 @default.
• W2616439347 hasRelatedWork W2049908604 @default.
• W2616439347 hasRelatedWork W2050283198 @default.
• W2616439347 hasRelatedWork W2056075233 @default.
• W2616439347 hasRelatedWork W2056385328 @default.
• W2616439347 hasRelatedWork W2220102944 @default.
• W2616439347 hasRelatedWork W2354177100 @default.
• W2616439347 hasRelatedWork W2577548098 @default.
• W2616439347 hasRelatedWork W2794789786 @default.
• W2616439347 hasRelatedWork W3031852375 @default.
• W2616439347 hasRelatedWork W3112940496 @default.
• W2616439347 hasVolume "101" @default.
• W2616439347 isParatext "false" @default.
• W2616439347 isRetracted "false" @default.
• W2616439347 magId "2616439347" @default.
• W2616439347 workType "article" @default.